APOE and Alzheimer disease: This study also evaluated AD biomarkers and APOE ε4 allele status to complement neurocognitive assessment, providing a key and novel understanding of how observed neurocognitive performance was associated (or not) with AD pathology in a vascular‐rich carotid disease cohort.